| EG |
Report |
Operating EPS |
BEAT |
pred ~$15.20 vs. cons ~$14.60 |
MEDIUM |
| EG |
Report |
Group Combined Ratio |
BEAT |
pred ~91.0% vs. cons ~93.5% |
MEDIUM |
| EG |
Report |
Net Investment Income |
BEAT |
pred ~$580M vs. cons ~$560M |
MEDIUM |
| EG |
Guide |
Quarterly buyback floor / capital return cadence |
BETTER |
guide ~$350M+ vs. cons ~$300M floor (Q3 2026) |
MEDIUM |
| EG |
Guide |
Casualty/Baltimore Bridge reserve true-up |
LOWER |
guide ~$40M incremental charge vs. cons/embedded ~$15-20M (Q2 2026) |
LOW |
| EG |
Guide |
FY2026 Legacy segment combined ratio / expense ratio outlook |
UNCHANGED |
guide >110% Legacy CR and 6-7% expense ratio vs. cons ~108-110% CR and ~6.3% expense ratio (FY2026) |
MEDIUM |
| EG |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.2% |
— |
MEDIUM |
| EG |
Return |
5-day cumulative residual |
-2.8% (FADE) |
Stock rallied ~23% off its June low and ~6.8% in the four sessions right before the print, pricing in a clean cat quarter and a beat; even with likely EPS/combined-ratio beats, continued property-cat rate softening (mid-teens at 6/1 Florida), an incremental casualty/Baltimore Bridge reserve add, and a still->110% Legacy drag imply modest downward revisions to 2H26/2027 estimates that outweigh the in-quarter beat, producing profit-taking and give-back over the week rather than follow-through. |
MEDIUM |